Related Experiment Video
Updated: Jan 21, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Regulatory T Cells: Pathophysiological Roles and Clinical Applications
Ryota Sakai1, Kyoko Komai1, Mana Iizuka-Koga1
1Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Regulatory T cells (Tregs) are crucial for immune tolerance and tissue repair. This study explores brain Tregs, a unique subtype, for potential therapeutic applications in stroke and graft-versus-host disease.
Area of Science:
- Immunology
- Neuroscience
- Regenerative Medicine
Background:
- Inflammation and immune responses are critical after tissue injury, influencing healing and fibrosis.
- Regulatory T cells (Tregs) mediate immune tolerance and are key targets for autoimmune disease and transplant rejection therapies.
- Tissue-resident Tregs possess unique functions for homeostasis and repair, offering potential for cell-based therapies.
Purpose of the Study:
- To investigate the therapeutic potential of Regulatory T cells (Tregs) in neurological recovery and immune suppression.
- To characterize brain-resident Tregs and their unique properties, including response to serotonin.
- To explore the application of Tregs in suppressing graft-versus-host disease and promoting neural recovery post-stroke.
Main Methods:
- Investigated transcriptional and epigenetic regulation of Foxp3 expression for Treg stabilization.
- Identified and characterized brain Tregs, noting their accumulation during chronic ischemic brain injury.
- Examined the unique expression of neural cell-specific genes, such as serotonin receptor (Htr7), in brain Tregs.
- Described experiences using Tregs to mitigate graft-versus-host disease and enhance neural recovery after stroke.
Main Results:
- Brain Tregs were discovered to accumulate in the brain during chronic ischemic injury.
- Brain Tregs exhibit unique characteristics, including the expression of neural genes like Htr7, and respond to serotonin.
- Tregs demonstrated efficacy in suppressing graft-versus-host disease.
- Tregs showed potential in promoting neural recovery following stroke.
Conclusions:
- Brain Tregs represent a distinct subset of tissue-resident Tregs with unique neuro-immune interactions.
- Treg-based cell therapy holds promise for managing autoimmune diseases, preventing transplant rejection, and promoting recovery from neurological injury.
- Targeting serotonin pathways in brain Tregs could offer novel therapeutic strategies for neurological disorders.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Cis-regulatory Sequences
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

